Assessing the total costs of blood delivery to hospital oncology and haematology patients

Current Medical Research and Opinion

Volumn 22, Issue 10, 2006, Pages 1903-1909

  Agrawal, Samir ^a   Davidson, Neville ^b   Walker, Mel ^c   Gibson, Sian ^b   Lim, Christina ^a   Morgan, Christopher Ll ^d   Cowell, Warren ^c  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b BROOMFIELD HOSPITAL   (United Kingdom)

^c ROCHE PRODUCTS LTD   (United Kingdom)

^d CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Anaemia; Blood transfusion; Cost; Erythropoietin; Oncology

Indexed keywords

ARTICLE; BLOOD BANK; BLOOD TRANSFUSION; CONTROLLED STUDY; COST BENEFIT ANALYSIS; ERYTHROCYTE; FEMALE; HOSPITAL COST; HOSPITAL DEPARTMENT; HOSPITAL SUBDIVISIONS AND COMPONENTS; HOSPITALIZATION; HUMAN; INFORMATION PROCESSING; MALE; MEDICAL STAFF; PATIENT CARE; QUALITY OF LIFE; UNITED KINGDOM;

BLOOD TRANSFUSION; GREAT BRITAIN; HEMATOLOGY; HOSPITAL COSTS; HOSPITALS, DISTRICT; HOSPITALS, TEACHING; HUMANS; NEOPLASMS; ONCOLOGY SERVICE, HOSPITAL;

EID: 33750519464     PISSN: 03007995     EISSN: None     Source Type: Journal    
DOI: 10.1185/030079906X132532     Document Type: Article

References (19)

1. Groopman JE, Itri LM. Chemotherapy-induced anaemia in adults: incidence and treatment. J Natl Cancer Inst 1999;91:1616-34
2. Littlewood TJ. Management options for cancer therapy-related anaemia. Drug Safety 2002;25:525-35
3. Guest JF, Munro V, Cookson RF. The annual cost of blood transfusions in the United Kingdom. Clin Lab Haematol 1998;20:111-8
4. NHS Executive. Government accepts advice on leucodepletion from spongiform encephalopathy advisory committee. London: Department of Health. Press release 1998/295
5. Varney SJ, Guest JF. The annual cost of blood transfusions in the UK. Transfus Med 2003;13:205-18
6. Currie CJ, Patel TC, McEwan P, et al. Evaluation of the future supply and demand for blood products in the United Kingdom National Health Service. Transfus Med 2003;14:19-24
7. UNISON pay and conditions. Available from http://www.unison. org.uk/pay/payscales.asp [Last accessed June 9th, 2006]
8. Cremieux PY, Barrett B, Anderson K, et al. Cost of outpatient blood transfusion in cancer patients. J Clin Oncol 2000;18:2755-61
9. De Cock E, van Bellinghen L, Fabre-Guillevin P, et al. Assessing provider time and costs for red blood cell (RBC) transfusions in anaemia management of cancer patients using the activity-based costing (ABC) method in France. Value Health 2003;6:735
10. Barrett-Lee PJ, Bailey NP, O'Brien MER, et al. Large-scale UK audit of blood transfusion requirements and anaemia in patients receiving cytotoxic chemotherapy. Br J Cancer 2000;82:93-7
11. McClelland B, Contreras M. Appropriateness and safety of blood transfusion. BMJ 2005;330:104-5
12. NBS National Prices Document. Available from http://www.blood.co.uk/ hospitals/library/pdf/components/national_prices_05_06.pdf [Last accessed 13th August 2006]
13. Littlewood TJ. Management options for cancer therapy-related anaemia. Drug Safety 2002;25:525-35
14. Cheer SM, Wagstaff AJ. Epoetin beta - a review of its clinical use in the treatment of anaemia in patients with cancer. Drugs 2004;64:323-46
15. Johansson JE, Wersall P, Brandberg Y, et al. efficacy of epoetin beta on hemoglobin, quality of life, and transfusion needs in patients with anemia due to hormone-refractory prostate cancer. Scand J Urol Nephrol 2001;35:288-94
16. Cavill I. Reducing blood transfusion. Focus should be on improving patients' ability to make own blood. BMJ 2002;325:655
17. Joint response - National Blood Service and Welsh Blood Service. Health technology appraisal. Cancer treatment induced anaemia: epoetin (alpha and beta) and darbepoetin alpha. Available from http://www.nice.org.uk/page.aspx?o=263335 [Last accessed June 9th, 2006]
18. NHS Executive. Better blood transfusion. Appropriate use of blood. London: Department of Health. Health Service Circular 2002
19. Bosanquet N, Tolley K. Treatment of anaemia in cancer patients: implications for supportive care in the National Health Service Cancer Plan. Curr Med Res Opin 2003;19:643-50